Jobs / United States / Novartis Pharmaceuticals Corporation

Novartis Pharmaceuticals Corporation

Novartis Venture Fund Analyst

Cambridge (USA) Posted today

Apply on employer site ↗ Tailor my CV first Source: Company careers site

Optional: we can tailor a CV and cover letter for this job from your real experience first (the first one is free).

Sponsorship verdict

Posting rules out sponsorship

The posting rules out sponsorship or requires citizenship or security clearance.

  • Employer is on a government sponsor recordThe US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
  • The posting says it won’t sponsorIts own wording says sponsorship is unavailable.
  • No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
  • Confirmed live todayWhen a source last listed this job as open.
Details and sources
Employer is on a government sponsor record
The US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
No salary bar for this route
H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.

US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).

A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.

Before you apply

Likely skip

The posting states sponsorship is unavailable. Applying is unlikely to lead anywhere if you need sponsorship.

These come from the posting’s own wording. Read the original listing to confirm. See better-fit alternatives →

About the role

Job Description Summary #LI-Hybrid Location: Cambridge, Boston Relocation Support: This role is based in Cambridge, Boston. Novartis is unable to offer relocation support: please only apply if accessible. Sponsorship: Novartis is unable to offer sponsorship for this role. Turn scientific insight into investment decisions that could help shape the future of medicine. As an Analyst with the Novartis Venture Fund, you'll join a small, highly collaborative team investing in innovative life sciences companies developing potentially paradigm-changing therapies in areas of high unmet need. You'll work alongside experienced venture investors across scientific and business due diligence, market and competitive analysis, investment evaluation and portfolio support, while building your understanding of the wider drug development and investment landscape. With exposure to senior decision-makers, entrepreneurs, company leaders and scientific experts, this is an opportunity to build on your scientific expertise, broaden your commercial perspective and develop as a life sciences venture investor.   Job Description Key Responsibilities ·    Support scientific and business due diligence for new and follow-on life sciences investments. ·    Evaluate scientific publications, business plans and emerging technologies to inform investment decisions. ·    Conduct competitive, market and landscape analyses across therapeutic areas and emerging science. ·    Engage with scientific experts and key opinion leaders to test investment hypotheses. ·    Assess companies, development programs and market opportunities alongside senior investment colleagues. ·    Build financial and capital models to support investment evaluation and decision-making. ·    Prepare clear investment memoranda, financial analyses and presentations for internal review. ·    Coordinate deal flow and maintain accurate documentation across prospective and existing investments. ·    Support portfolio companies by coordinating interactions across the Novartis Venture Fund and wider Novartis organization. ·    Collaborate with senior colleagues and external stakeholders across the life sciences and venture capital ecosystem. Essential Requirements ·    Doctor of Philosophy and/or Doctor of Medicine in natural sciences, medicine or a closely related discipline. ·    At least two years' experience within the pharmaceutical, biotechnology or investment industry. ·    Strong scientific expertise with an understanding of life sciences, drug development, medical needs and emerging scientific trends. ·    Experience with, or strong understanding of, scientific due diligence and evaluating scientific evidence. ·    Strong analytical and conceptual skills, with the ability to connect scientific insight with broader business and market considerations. ·    Excellent written and verbal communication skills, including confidence engaging with senior stakeholders and external experts. ·    Ability to prioritize and manage multiple projects effectively in an international, high-performance environment. ·    Proactive, collaborative and intellectually curious approach, with a strong interest in research, analysis and life sciences investing. Desirable Requirements ·    Master of Business Administration or equivalent business education would be an advantage. ·    Additional language capabilities beyond fluent English would be beneficial. Why Novartis? At Novartis, our purpose is to reimagine medicine to improve and extend people’s lives. As a Novartis Venture Fund Analyst, you will have the opportunity to help evaluate breakthrough science and emerging life sciences companies with the potential to address significant unmet medical needs. Working alongside experienced venture investors, entrepren

Apply on employer site ↗